High prevalence of malnutrition in systemic sclerosis: Results from a French monocentric cross-sectional study.


Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 17 03 2023
revised: 08 07 2023
accepted: 23 07 2023
medline: 14 11 2023
pubmed: 15 10 2023
entrez: 14 10 2023
Statut: ppublish

Résumé

Systemic sclerosis (SSc) can cause malnutrition due to frequent gastrointestinal involvement. However, prevalence of malnutrition in SSc is poorly known. The aim of this study was to evaluate the prevalence of malnutrition in SSc and its potential associations with disease features in patients from a tertiary referral center. All patients meeting American College of Rheumatology/European Alliance of Associations for Rheumatology criteria for SSc followed between January 1, 1985, and January 1, 2019, at the Department of Internal Medicine, Saint Eloi University Hospital, were included. Malnutrition was assessed using the 2020 French recommendations for SSc and the malnutrition universal screening tool score. Severe malnutrition was defined via the French Haute Autorité de Santé (National Health Authority) 2007 criteria. A total of 120 patients were included, with mean age 64 (± 15) y and a female-to-male sex ratio of 5:1. According to 2020 French recommendations, 71 patients (59.2%) were malnourished and 30 (25%) had at least one criterion of severe malnutrition. With the malnutrition universal screening tool score, 41.7%, 20%, and 38.3%, respectively, had low, medium, and high risk of malnutrition. Multivariate analysis revealed the following results: 1) malnutrition was associated with cardiac involvement (P < 0.01); 2) a high malnutrition universal screening tool score was also associated with specific cardiac involvement (P < 0.01); and 3) severe malnutrition was strongly correlated with interincisal distance <35 mm (P = 0.02). Malnutrition affects more than half of SSc patients and is associated with specific cardiac involvement. Interincisal distance <35 mm could be a red flag for severe malnutrition in SSc.

Identifiants

pubmed: 37837826
pii: S0899-9007(23)00199-5
doi: 10.1016/j.nut.2023.112171
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112171

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Valérian Rivet (V)

Internal Medicine and Immunopathology Departement, Cancer University of Toulouse Oncopole, University Hospital Center of Toulouse, Toulouse, France.

Sophie Riviere (S)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Radjiv Goulabchand (R)

Montpellier University Hospital, Montpellier, France; Departement of Internal Medicine, University Hospital Center of Nîmes, Nîmes, France.

Benoît Suzon (B)

Department of Internal Medicine, University Hospital of Martinique, Fort-de-France, Martine, France.

Pierrick Henneton (P)

Montpellier University Hospital, Montpellier, France; Vascular Department of Internal Medicine, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Léo Partouche (L)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Patricia Rullier (P)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Alain Le Quellec (AL)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France; Montpellier University Hospital, Montpellier, France.

Amadou Konate (A)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Aurélie Schiffmann (A)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Thierry Vincent (T)

Immunology Laboratory, Department of Immunology, Saint-Eloi Hospital, CHRU Montpellier, France.

Rahima Ziane (R)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France.

Nicolas Flori (N)

Gastroenterology Unit, Department of Gastroenterology and Nutrition, Cancer Institute of Montpellier, Montpellier, France.

Marie Christine Picot (MC)

Montpellier University Hospital, Montpellier, France; Clinical Research and Epidemiology Unit, Medical Information Department, INSERM, Clinical Investigator Center, University Hospital Center of Montpellier, Montpellier, France.

Ariane Sultan (A)

Montpellier University Hospital, Montpellier, France; Diabetes Nutrition Unit, Endocrinology Department, Lapeyronie Hospital, University Hospital Center of Montpellier, Montpellier, France; PhyMedExp, Montpellier University, INSERM, CNRS, University Hospital Center of Montpellier, Montpellier, France.

Alexandre Thibaut Jacques Maria (ATJ)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France; Montpellier University Hospital, Montpellier, France; Department of Internal Medicine and Immuno-Oncology (MEDI²O), Institute for Regenerative Medicine and Biotherapy (IRMB), Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France. Electronic address: a-maria@chu-montpellier.fr.

Philippe Guilpain (P)

Department of Internal Medicine: Multi-Organic Diseases, Saint-Eloi Hospital, University Hospital Center of Montpellier, Montpellier, France; Montpellier University Hospital, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH